Small interfering RNA(siRNA), a representative therapeutic tool for targeted therapy and precision medicine, can silence the expression of any disease-related gene through sequence-specific RNA interference(RNAi). However, its therapeutic prospects have historically been limited by short half-lives in vivo, difficulties in delivery, and safety concerns. Non-viral vector drug delivery has efficiently achieved siRNA delivery in vivo and silenced the target gene, becoming a successful strategy to overcome above limitations. Currently, several drugs are already in clinical trials, and four new siRNA-based therapies have been approved recently by the U.S. FDA, marking the beginning of a new era of targeted therapies. This review summarizes the recent development and application of siRNA-based non-viral vector delivery strategies and predicts the future development trend of siRNA drug research.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |